From: Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients
 | rtPA with Cholesterol Reducer |  | rtPA without Cholesterol Reducer |  | ||
---|---|---|---|---|---|---|
Characteristic | NIHSS ≤ 7 | NIHSS > 7 |  | NIHSS ≤ 7 | NIHSS > 7 | |
Number of patients | 321 | 309 | P-value | 306 | 381 | P-Value |
Age Group: No. (%) | ||||||
  < 50 years | 32 (10.0) | 20 (6.5) | < 0.001*a | 79 (25.8) | 60 (15.7) | < 0.001*a |
 50–59 | 59 (18.4) | 44 (14.2) |  | 75 (24.5) | 80 (21.0) |  |
 60–69 | 103 (32.1) | 73 (23.6) |  | 71 (23.2) | 67 (17.6) |  |
 70–79 | 81 (25.2) | 76 (24.6) |  | 49 (16.0) | 80 (21.0) |  |
  > =80 | 46 (14.3) | 96 (31.1) |  | 32 (10.5) | 94 (24.7) |  |
Age Mean ± SD | 65.95 ± 12.09 | 70.83 ± 13.26 | < 0.001*b | 59.67 ± 15.47 | 66.31 ± 15.82 | < 0.001*b |
Race: No (%) | ||||||
 White | 277 (86.3) | 244 (79.0) | 0.050*a | 243 (79.4) | 287 (75.3) | 0.446 |
 Black | 37 (11.5) | 56 (18.1) |  | 54 (17.6) | 80 (21.0) |  |
 Other | 7 (2.2) | 9 (2.9) |  | 9 (2.9) | 14 (3.7) |  |
Gender: No. (%) | ||||||
 Female | 130 (40.5) | 159 (51.5) | 0.006*a | 159 (52.0) | 205 (53.8) | 0.630 |
 Male | 191 (59.5) | 150 (48.5) |  | 147 (48.0) | 176 (46.2) |  |
Hispanic Ethnicity: No. (%) | 7 (2.2) | 8 (2.6) | 0.737 | 5 (1.6) | 10 (2.6) | 0.377 |
BMI: Mean ± SD | 29.72 ± 6.67 | 28.94 ± 7.72 | 0.180 | 29.07 ± 6.72 | 27.83 ± 6.24 | 0.014*b |
Medical History: No. (%) | ||||||
 Atrial Fib | 37 (11.5) | 74 (23.9) | < 0.001*a | 35 (11.4) | 62 (16.3) | 0.070 |
 Coronary Artery Disease | 135 (42.1) | 135 (43.7) | 0.679 | 50 (16.3) | 74 (19.4) | 0.296 |
 Carotid Artery Stenosis | 24 (7.5) | 17 (5.5) | 0.315 | 4 (1.3) | 11 (2.9) | 0.159 |
 Depression | 58 (18.1) | 60 (19.4) | 0.664 | 39 (12.7) | 48 (12.6) | 0.954 |
 Diabetes | 135 (42.1) | 124 (40.1) | 0.623 | 66 (21.6) | 86 (22.6) | 0.753 |
 Drugs or Alcohol | 14 (4.4) | 19 (6.1) | 0.314 | 15 (4.9) | 28 (7.3) | 0.188 |
 Dyslipidemia | 273 (85.0) | 265 (85.8) | 0.800 | 75 (24.5) | 81 (21.3) | 0.312 |
 Stroke Family History | 45 (14.0) | 22 (7.1) | 0.005*a | 39 (12.7) | 24 (6.3) | 0.004*a |
 Heart Failure | 31 (9.7) | 47 (15.2) | 0.034*a | 16 (5.2) | 41 (10.8) | 0.009*a |
 Hormonal Replacement Therapy | 10 (3.1) | 7 (2.3) | 0.510 | 8 (2.6) | 6 (1.6) | 0.338 |
 Hypertension | 291 (90.7) | 289 (93.5) | 0.182 | 182 (59.5) | 273 (71.7) | 0.001*a |
 Migraine | 11 (3.4) | 7 (2.3) | 0.382 | 19 (6.2) | 8 (2.1) | 0.006*a |
 Obesity | 187 (58.3) | 146 (47.2) | 0.006*a | 172 (56.2) | 173 (45.4) | 0.005*a |
 Previous Stroke | 90 (28.0) | 90 (29.1) | 0.762 | 46 (15.0) | 62 (16.3) | 0.657 |
 Previous TIA (> 24 h) | 45 (14.0) | 41 (13.3) | 0.784 | 25 (8.2) | 30 (7.9) | 0.887 |
 Prosthetic Heart Valve | 2 (0.6) | 4 (1.3) | 0.386 | 1 (0.3) | 3 (0.8) | 0.430 |
 Peripheral Vascular Disease | 25 (7.8) | 25 (8.1) | 0.888 | 12 (3.9) | 16 (4.2) | 0.855 |
 Chronic Renal Disease | 23 (7.2) | 24 (7.8) | 0.774 | 11 (3.6) | 21 (5.5) | 0.236 |
 Sleep Apnea | 16 (5.0) | 15 (4.9) | 0.940 | 9 (2.9) | 5 (1.3) | 0.133 |
 Smoker | 88 (27.4) | 69 (22.3) | 0.140 | 117 (38.2) | 111 (29.1) | 0.012*a |
Medication History: No (%) | ||||||
 HTN medication | 286 (89.1) | 283 (91.6) | 0.291 | 150 (49.0) | 216 (56.7) | 0.045*a |
 Diabetes medication | 117 (36.4) | 106 (34.3) | 0.574 | 45 (14.7) | 60 (15.7) | 0.706 |
 Antidepressant | 63 (19.6) | 64 (20.7) | 0.734 | 44 (14.4) | 51 (13.4) | 0.708 |
Lab values: Mean ± SD | ||||||
 Total cholesterol | 155.76 ± 41.36 | 153.88 ± 46.06 | 0.598 | 184.85 ± 46.97 | 178.75 ± 43.84 | 0.087 |
 Triglycerides | 149.43 ± 115.24 | 133.22 ± 100.57 | 0.067 | 153.54 ± 119.4 | 128.33 ± 95.18 | 0.003*b |
 HDL | 39.51 ± 11.76 | 40.65 ± 12.61 | 0.250 | 42.49 ± 15.41 | 44.19 ± 14.03 | 0.140 |
 LDL | 91.22 ± 34.93 | 88.74 ± 37.96 | 0.404 | 116.22 ± 38.58 | 112.65 ± 37.26 | 0.230 |
 Lipids | 6.37 ± 1.61 | 6.33 ± 1.45 | 0.727 | 6.17 ± 1.69 | 6.17 ± 1.65 | 0.973 |
 Blood Glucose | 136.22 ± 63.35 | 147.04 ± 73.66 | 0.049*b | 138.19 ± 81.28 | 143.76 ± 79.88 | 0.372 |
 Serum Creatinine | 1.15 ± 0.54 | 1.21 ± 0.79 | 0.233 | 1.04 ± 0.4 | 1.16 ± 1.04 | 0.036*b |
 Initial Platelet Count | 159,087.99 ± 131,106.09 | 170,621.77 ± 120,785.15 | 0.519 | 196,175.97 ± 133,607.09 | 175,315.17 ± 128,742.52 | 0.245 |
 INR | 1.04 ± 0.12 | 1.07 ± 0.12 | 0.005*b | 1.04 ± 0.15 | 1.07 ± 0.18 | 0.016*b |
Vital Signs: Mean ± SD | ||||||
 Heart Rate | 79.62 ± 15.03 | 81.31 ± 17.38 | 0.191 | 80.71 ± 16.21 | 84.98 ± 18.94 | 0.002*b |
 Blood Pressure Systolic | 150.34 ± 25.3 | 150.94 ± 26.19 | 0.768 | 151.62 ± 28.49 | 152.87 ± 27.51 | 0.561 |
 Blood Pressure Diastolic | 81.42 ± 16.2 | 80.44 ± 17.35 | 0.465 | 84.92 ± 19.27 | 84.82 ± 19.41 | 0.941 |
Ambulation Status Prior to Event: No. (%) | ||||||
 Ambulate Independently | 315 (98.1) | 276 (89.3) | < 0.001*a | 297 (97.1) | 361 (94.8) | 0.038*a |
 Ambulate with Assistance | 2 (0.6) | 9 (2.9) |  | 7 (2.3) | 5 (1.3) |  |
 Unable to Ambulate | 2 (0.6) | 10 (3.2) |  | 1 (0.3) | 7 (1.8) |  |
 Not Documented | 2 (0.6) | 14 (4.5) |  | 1 (0.3) | 8 (2.1) |  |
Ambulation Status on Admission: No. (%) | ||||||
 Ambulate Independently | 93 (29.0) | 17 (5.5) | < 0.001*a | 95 (31.0) | 24 (6.3) | < 0.001*a |
 Ambulate with Assistance | 98 (30.5) | 50 (16.2) |  | 104 (34.0) | 52 (13.6) |  |
 Unable to Ambulate | 18 (5.6) | 198 (64.1) |  | 21 (6.9) | 238 (62.5) |  |
 Not Documented | 112 (34.9) | 44 (14.2) |  | 86 (28.1) | 67 (17.6) |  |
Ambulation Status on Discharge: No. (%) | ||||||
 Ambulate Independently | 224 (69.8) | 86 (27.8) | < 0.001*a | 217 (70.9) | 128 (33.6) | < 0.001*a |
 Ambulate with Assistance | 76 (23.7) | 98 (31.7) |  | 78 (25.5) | 100 (26.2) |  |
 Unable to Ambulate | 12 (3.7) | 88 (28.5) |  | 9 (2.9) | 111 (29.1) |  |
 Not Documented | 1 (0.3) | 1 (0.3) |  | 0 (0.0) | 2 (0.5) |  |
First Care Received: No. (%) | ||||||
 Emergency Department | 216 (67.3) | 261 (84.5) | < 0.001*a | 221 (72.7) | 310 (82.2) | 0.003*a |
 Direct Admission | 105 (32.7) | 48 (15.5) |  | 83 (27.3) | 67 (17.8) |  |
 Improved Ambulation: No (%) | 177 (56.5) | 151 (55.3) | 0.763 | 162 (53.3) | 193 (56.5) | 0.399 |